查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423559

到 2030 年静脉曲张治疗市场预测：按产品类型、最终用户和地区分類的全球分析

Varicose Vein Treatment Market Forecasts to 2030 - Global Analysis By Product, Treatment Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球静脉曲张治疗市场规模为 14 亿美元，预计预测期内复合年增长率为 8.3%，到 2030 年将达到 24 亿美元。

静脉曲张治疗涉及旨在解决和缓解与静脉曲张相关的症状的医疗干预措施。静脉曲张是一种扩大、扭曲的静脉，通常出现在小腿上，是由静脉壁或瓣膜变弱或损坏引起的。生活方式的改变，如定期运动、维持健康的体重和抬高双腿，可以补充这些医疗干预措施。

提高患者意识

患者现在更愿意咨询医疗保健专业人员以进行及时诊断并探索可用的治疗方法，从生活方式的改变到微创手术。这种认知的提高延伸到了未经治疗的静脉曲张的医疗后果，例如静脉功能不全和溃疡，以及与可见静脉相关的美容问题。此外，对预防性医疗保健和早期疗育的关注鼓励及时解决静脉问题，对静脉曲张治疗市场产生积极影响。

高成本

评估静脉曲张的严重程度和根本原因所需的诊断测试（例如超音波影像成像）可能需要专门的设备、熟练的医疗专业人员和多次治疗，这会导致更高的成本。保险范围和报销政策也会影响静脉曲张治疗的经济效益。此外，高昂的治疗成本对低收入和保险不足的个人产生了不成比例的影响，导致取得和结果方面的差异，阻碍了该市场的规模。

改善医疗基础设施

医疗设施的进步，例如专门静脉曲张诊所的建立和现代设备的可用性，有助于改善静脉曲张患者的就诊机会并提高护理品质。这些设施整合了最新技术并遵守严格的医疗标准，让患者受益于更安全、更有效的治疗。此外，专门从事静脉疾病的熟练医疗专业人员的存在进一步加强了基础设施并支持该市场的扩张。

缺乏意识

缺乏症状会导致诊断和介入的延误，患者可能直到症状变得严重才寻求医疗协助。由于缺乏公共教育工作以及有关静脉曲张和现有治疗方法的资讯普及有限，这项挑战进一步加剧。此外，结果，很大一部分人仍然不了解早期疗育的重要性，阻碍了这个市场。

COVID-19 的影响

COVID-19 大流行从多个方面对静脉曲张治疗市场产生了负面影响。关闭医疗设施、限制非必要医疗程序以及将医疗资源重新分配给与大流行相关的活动，大大减少了选择性手术的数量，包括静脉曲张治疗。此外，大流行期间的经济不确定性和财政限制导致医疗保健支出下降，阻碍了该市场的规模。

静脉缝合产品领域预计将在预测期内成为最大的领域

由于设计用于闭合或密封受影响的静脉以解决静脉功能不全和静脉曲张的医疗设备范围广泛，静脉缝合产品领域预计将占据最大份额。这些产品在微创治疗中发挥重要作用，旨在将血流重定向到更健康的静脉。此外，这些静脉缝合产品正在推动微创介入的成长趋势，为患者提供传统手术方法的有效替代方案，推动这一领域的扩张。

注射硬化疗法预计在预测期内复合年增长率最高

注射硬化疗法预计在预测期内复合年增长率最高。在这项技术中，将固化溶液直接注射到受影响的静脉中，使其崩坏并最终被吸收到体内。这对小静脉曲张和蜘蛛网状静脉曲张特别有效。此外，注射硬化疗法因其简单、负担得起和门诊病人性质而通常受到青睐，使其成为患者和医疗保健提供者的热门选择，并推动了这一领域的扩张。我就是。

比最大的地区

由于人口老化、生活方式的改变和意识的提高等因素，亚太地区在预测期内占据了最大的市场占有率。 Medtronic PLC、Alma Lasers Ltd.、Teleflex Incorporated 和 Boston Scientific 等主要企业正在采用微创手术，如静脉注射雷射治疗 (EVLT)、射频消融治疗 (RFA) 和注射硬化疗法。此外，随着医疗保健系统的不断发展以及对微创和有效治疗的需求持续增长，该市场预计将进一步扩大。

复合年增长率最高的地区：

由于人们对静脉健康的认识不断提高，预计欧洲在预测期内的复合年增长率最高。这反映了微创手术的趋势，例如静脉注射雷射治疗（EVLT）、射频消融治疗（RFA）和注射硬化疗法。此外，欧洲患者越来越多地寻求恢復时间更快的门诊选择，而这些侵入性较小的手术的普及正在推动该地区的成长。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球静脉曲张治疗市场：副产品

  • 静脉缝合产品
  • 消融装置
    • 射频消融术装置
    • 雷射消熔装置
  • 手术产品
  • 其他产品

第六章全球静脉曲张治疗市场：依治疗类型

  • 手术结扎/剥离
  • 静脉消融
  • 注射硬化疗法
  • 其他治疗类型

第七章全球静脉曲张治疗市场：依最终使用者分类

  • 静脉诊所
  • 门诊治疗室
  • 医院
  • 其他最终用户

第八章全球静脉曲张治疗市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Medtronic PLC
  • Dornier MedTech GmbH
  • Candela Medical
  • Won Tech Co. Ltd
  • Boston Scientific
  • Sciton Inc.
  • El. En SpA Group
  • Alma Lasers Ltd
  • Teleflex Incorporated
  • AngioDynamics Inc.
  • Eufoton SRL
  • Biolitec AG
Product Code: SMRC24793

According to Stratistics MRC, the Global Varicose Vein Treatment Market is accounted for $1.4 billion in 2023 and is expected to reach $2.4 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Varicose vein treatment involves medical interventions aimed at addressing and alleviating the symptoms associated with varicose veins. Varicose veins are enlarged, twisted veins that commonly appear in the legs and result from weakened or damaged vein walls and valves. Lifestyle modifications, such as regular exercise, maintaining a healthy weight, and elevating the legs, can complement these medical interventions.

Market Dynamics:

Driver:

Rising patient awareness

Patients are now more proactive in consulting healthcare professionals for timely diagnosis and exploring available treatment modalities, ranging from lifestyle modifications to minimally invasive procedures. This heightened awareness extends to both the medical implications of untreated varicose veins, such as venous insufficiency and ulceration, and the aesthetic concerns associated with visible veins. Furthermore, the emphasis on preventive healthcare and early intervention has encouraged individuals to address venous issues promptly, fostering a positive impact on the varicose vein treatment market.

Restraint:

High cost

Diagnostic tests such as ultrasound imaging, which are necessary to assess the severity and underlying causes of varicose veins, may require specialized equipment, skilled healthcare professionals, and multiple sessions, leading to higher costs. Insurance coverage and reimbursement policies can also impact the affordability of varicose vein treatment. Moreover, the high cost of treatment can disproportionately affect individuals with lower incomes or inadequate insurance coverage, leading to disparities in healthcare access and outcomes, which is hampering this market size.

Opportunity:

Improving healthcare infrastructure

Advances in medical facilities, including the establishment of specialized vein clinics and the availability of state-of-the-art equipment, contribute to enhanced accessibility and quality of care for individuals with varicose veins. As these facilities integrate modern technologies and adhere to stringent medical standards, patients benefit from safer and more effective interventions. Additionally, the presence of skilled healthcare professionals specializing in venous disorders further strengthens the infrastructure, which is propelling this market's expansion.

Threat:

Lack of awareness

The lack of awareness contributes to delayed diagnosis and intervention, as patients may not seek medical advice until symptoms become severe. The absence of public education initiatives and the limited dissemination of information about varicose veins and available treatment options further exacerbate this challenge. Moreover, as a result, a substantial portion of the population remains uninformed about the importance of early intervention, thereby hindering this market.

Covid-19 Impact

The COVID-19 pandemic has negatively impacted the varicose vein treatment market in several ways. Lockdowns, restrictions on non-essential medical procedures, and the reallocation of healthcare resources to pandemic-related activities led to a significant decline in the number of elective procedures, including varicose vein treatments. Additionally, economic uncertainties and financial constraints during the pandemic resulted in reduced healthcare spending, thereby hampering this market size.

The venous closure products segment is expected to be the largest during the forecast period

The venous closure products segment is estimated to hold the largest share due to a range of medical devices designed to address venous insufficiency and varicose veins by closing or sealing affected veins. These products play a crucial role in minimally invasive treatments that aim to redirect blood flow to healthier veins. Further, these venous closure products contribute to the growing trend of minimally invasive interventions, providing patients with effective alternatives to traditional surgical approaches, which is boosting this segment's expansion.

The injection sclerotherapy segment is expected to have the highest CAGR during the forecast period

The injection sclerotherapy segment is anticipated to have highest CAGR during the forecast period. This technique involves injecting a sclerosing solution directly into the affected veins, causing them to collapse and eventually be absorbed by the body. It is particularly effective for smaller varicose veins and spider veins. Furthermore, injection sclerotherapy is often preferred for its simplicity, affordability, and outpatient nature, making it a popular choice for both patients and healthcare providers, driving this segment's expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to factors such as population aging, lifestyle changes, and increasing awareness. Key players such as Medtronic PLC, Alma Lasers Ltd., Teleflex Incorporated, and Boston Scientific are adopting minimally invasive procedures like endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and injection sclerotherapy. In addition, as healthcare systems continue to evolve and the demand for effective, less-invasive interventions persists, this market is poised for further expansion.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to growing awareness of venous health. It reflects a trend toward minimally invasive procedures, such as endovenous laser treatment (EVLT), radiofrequency ablation (RFA), and injection sclerotherapy. Moreover, patients in Europe are increasingly seeking outpatient options with shorter recovery times, contributing to the popularity of these less invasive techniques, which are propelling this region's growth.

Key players in the market

Some of the key players in the Varicose Vein Treatment Market include Medtronic PLC, Dornier MedTech GmbH, Candela Medical, Won Tech Co. Ltd, Boston Scientific, Sciton Inc., El. En SpA Group, Alma Lasers Ltd, Teleflex Incorporated, AngioDynamics Inc., Eufoton SRL and Biolitec AG

Key Developments:

In December 2023, Teleflex Incorporated announced it was awarded the Peripheral Access purchasing agreement with Premier, Inc. Effective December 1st, 2023, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Teleflex's Peripheral Access products.

In November 2023, Medtronic plc announced that the United States Food and Drug Administration (FDA) have approved the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension.

In November 2023, Boston Scientific Corporation announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain.

Products Covered:

  • Venous Closure Products
  • Ablation Devices
  • Surgical Products
  • Other Products

Treatment Types Covered:

  • Surgical Ligation/Stripping
  • Endovenous Ablation
  • Injection Sclerotherapy
  • Other Treatment Types

End Users Covered:

  • Vein Clinics
  • Ambulatory Care Unit
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Varicose Vein Treatment Market, By Product

  • 5.1 Introduction
  • 5.2 Venous Closure Products
  • 5.3 Ablation Devices
    • 5.3.1 Radiofrequency Ablation Devices
    • 5.3.2 Laser Ablation Devices
  • 5.4 Surgical Products
  • 5.5 Other Products

6 Global Varicose Vein Treatment Market, By Treatment Type

  • 6.1 Introduction
  • 6.2 Surgical Ligation/Stripping
  • 6.3 Endovenous Ablation
  • 6.4 Injection Sclerotherapy
  • 6.5 Other Treatment Types

7 Global Varicose Vein Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Vein Clinics
  • 7.3 Ambulatory Care Unit
  • 7.4 Hospitals
  • 7.5 Other End Users

8 Global Varicose Vein Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Medtronic PLC
  • 10.2 Dornier MedTech GmbH
  • 10.3 Candela Medical
  • 10.4 Won Tech Co. Ltd
  • 10.5 Boston Scientific
  • 10.6 Sciton Inc.
  • 10.7 El. En SpA Group
  • 10.8 Alma Lasers Ltd
  • 10.9 Teleflex Incorporated
  • 10.10 AngioDynamics Inc.
  • 10.11 Eufoton SRL
  • 10.12 Biolitec AG

List of Tables

  • Table 1 Global Varicose Vein Treatment Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 4 Global Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 5 Global Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 6 Global Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 7 Global Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 8 Global Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 9 Global Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 10 Global Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 8 Global Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 9 Global Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 10 Global Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 14 Global Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 15 Global Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 16 Global Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 17 Global Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 18 Global Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 19 North America Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 20 North America Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 21 North America Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 22 North America Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 23 North America Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 24 North America Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 25 North America Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 26 North America Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 27 North America Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 28 North America Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 29 North America Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 30 North America Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 31 North America Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 32 North America Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 North America Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 34 North America Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 35 North America Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 North America Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Asia Pacific Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 39 Asia Pacific Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 40 Asia Pacific Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 41 Asia Pacific Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 42 Asia Pacific Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 43 Asia Pacific Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 44 Asia Pacific Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 45 Asia Pacific Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 46 Asia Pacific Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 47 Asia Pacific Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 48 Asia Pacific Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 49 Asia Pacific Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 50 Asia Pacific Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 51 Asia Pacific Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 52 Asia Pacific Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 53 Asia Pacific Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 54 Asia Pacific Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 55 Europe Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 56 Europe Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 57 Europe Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 58 Europe Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 59 Europe Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 60 Europe Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 61 Europe Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 62 Europe Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 63 Europe Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 64 Europe Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 65 Europe Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 66 Europe Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 67 Europe Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 68 Europe Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Europe Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 70 Europe Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 71 Europe Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 72 Europe Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 South America Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 South America Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 South America Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 76 South America Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 77 South America Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 78 South America Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 79 South America Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 80 South America Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 81 South America Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 82 South America Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 83 South America Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 84 South America Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 85 South America Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 86 South America Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 87 South America Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 88 South America Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 89 South America Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 90 South America Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 91 Middle East & Africa Varicose Vein Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 92 Middle East & Africa Varicose Vein Treatment Market Outlook, By Product (2021-2030) ($MN)
  • Table 93 Middle East & Africa Varicose Vein Treatment Market Outlook, By Venous Closure Products (2021-2030) ($MN)
  • Table 94 Middle East & Africa Varicose Vein Treatment Market Outlook, By Ablation Devices (2021-2030) ($MN)
  • Table 95 Middle East & Africa Varicose Vein Treatment Market Outlook, By Radiofrequency Ablation Devices (2021-2030) ($MN)
  • Table 96 Middle East & Africa Varicose Vein Treatment Market Outlook, By Laser Ablation Devices (2021-2030) ($MN)
  • Table 97 Middle East & Africa Varicose Vein Treatment Market Outlook, By Surgical Products (2021-2030) ($MN)
  • Table 98 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 99 Middle East & Africa Varicose Vein Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 100 Middle East & Africa Varicose Vein Treatment Market Outlook, By Surgical Ligation/Stripping (2021-2030) ($MN)
  • Table 101 Middle East & Africa Varicose Vein Treatment Market Outlook, By Endovenous Ablation (2021-2030) ($MN)
  • Table 102 Middle East & Africa Varicose Vein Treatment Market Outlook, By Injection Sclerotherapy (2021-2030) ($MN)
  • Table 103 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 104 Middle East & Africa Varicose Vein Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 105 Middle East & Africa Varicose Vein Treatment Market Outlook, By Vein Clinics (2021-2030) ($MN)
  • Table 106 Middle East & Africa Varicose Vein Treatment Market Outlook, By Ambulatory Care Unit (2021-2030) ($MN)
  • Table 107 Middle East & Africa Varicose Vein Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 108 Middle East & Africa Varicose Vein Treatment Market Outlook, By Other End Users (2021-2030) ($MN)